Makiren

Mometasone furoate, the active ingredient in Makiren, is a corticosteroid presented as a topical formulation for skin use. It is prescribed to manage inflammatory dermatoses such as atopic dermatitis, psoriasis and contact dermatitis in patients requiring anti‑inflammatory therapy. Its high potency allows effective symptom control with once‑daily application in many cases.

GNH USA supplies Makiren as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets.

Mometasone furoate is a topical corticosteroid that reduces inflammation in various skin disorders.

Atopic dermatitis: reduces redness, scaling and itching associated with the condition. Psoriasis: decreases plaque formation and inflammation. Contact dermatitis: alleviates irritation caused by allergic or irritant exposures. Other inflammatory skin conditions: provides symptomatic relief in conditions such as seborrheic dermatitis or lichen planus.

Topical application of mometasone furoate may be associated with local and systemic adverse reactions.

Common Side Effects: - Skin burning or stinging - Pruritus - Dryness or peeling

Serious or Rare Side Effects: - Hypothalamic‑pituitary‑adrenal axis suppression - Severe skin atrophy or striae - Secondary infection of treated area

When using Makiren, consider the following precautions to minimize risks.

Avoid use on infected or broken skin: consult a healthcare professional before application. Limit duration of therapy: prolonged use may increase risk of skin atrophy. Do not apply under occlusive dressings unless directed: may enhance systemic absorption. Use the smallest effective amount: to minimize adverse effects. Pregnancy and lactation: safety not established, weigh benefits against risks. Store at room temperature: keep in original container, protect from moisture and light.

Mometasone furoate may interact with other agents that affect steroid metabolism or absorption.

Major Interactions (Avoid): - Systemic corticosteroids: concurrent use may increase risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise local drug levels.

Moderate Interactions (Monitor Closely): - Topical antifungal agents applied to same area: may alter absorption. - Occlusive dressings: increase percutaneous absorption, monitor for side effects. - Other topical steroids: additive potency, adjust treatment accordingly.